​

10x Genomics Ownership | Who Owns 10x Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

10x Genomics Ownership Summary

10x Genomics is owned by 94.00% institutional investors, 1.82% insiders, and 4.18% retail investors. Vanguard group is the largest institutional shareholder, holding 10.73% of TXG shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 7.41% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock10x Genomics94.00%1.82%4.18%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryHealthcare Information Services Stocks 41.37%12.81%45.81%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group13.27M10.73%$155.18M
Ark investment management11.89M9.61%$138.96B
Blackrock funding, inc. /de9.46M7.64%$110.59M
Fmr8.46M6.83%$98.87M
Blackrock6.39M5.35%$124.34M
Sumitomo mitsui trust5.38M4.35%$62.91M
Nikko asset management americas5.38M4.34%$62.86M
Wellington management group llp4.29M3.46%$50.10M
Quantinno capital management lp3.49M2.82%$40.83M
Morgan stanley2.82M2.28%$32.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venrock management vi2.11M100.00%$40.98M
Lancaster investment management621.78K3.12%$7.27M
Tao capital management lp210.86K1.86%$2.46M
Sands capital ventures481.77K1.23%$5.63M
Exome asset management163.66K1.16%$1.91M
Ark investment management11.89M0.83%$138.96B
Nikko asset management americas5.38M0.61%$62.86M
Friedenthal financial79.03K0.48%$923.90K
Bayforest capital71.83K0.40%$839.66K
Iq eq fund management (ireland)479.33K0.38%$5.60M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp4.29M0.01%2.39M
Goldman sachs group2.68M0.00%2.07M
Quantinno capital management lp3.49M0.11%1.26M
Royal bank of canada1.43M0.00%1.22M
D. e. shaw1.22M0.01%1.22M

Top Sellers

HolderShares% AssetsChange
Generation investment management llp---2.88M
Ark investment management11.89M0.83%-2.00M
Brown capital management---1.84M
Assenagon asset management14.58K0.00%-1.70M
Point72 asset management---1.23M

New Positions

HolderShares% AssetsChangeValue
D. e. shaw1.22M0.01%1.22M$17.50M
Lancaster investment management621.78K3.12%621.78K$7.27M
Connor, clark & lunn investment management317.47K0.01%317.47K$3.71B
Exoduspoint capital management, lp251.73K0.03%251.73K$2.94M
Ossiam229.30K0.03%229.30K$2.68M

Sold Out

HolderChange
Concourse financial group securities-3.00
Mather group, llc.-4.00
Manchester capital management-4.00
Northwest investment counselors-6.00
Princeton global asset management-9.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252961.72%116,328,6192.84%931.13%157-14.21%8320.29%
Jun 30, 20252997.94%122,334,8068.44%981.17%18519.35%73-1.35%
Mar 31, 2025277-0.72%113,747,6058.46%921.22%1553.33%74-20.43%
Dec 31, 2024264-1.86%102,915,574-1.38%851.14%143-10.06%8519.72%
Sep 30, 20242671.14%104,336,340-0.97%861.12%1578.28%71-7.79%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite9.22M7.41%555.60K
ARK Innovation ETF7.15M5.74%-109.56K
Vanguard US Total Market Shares ETF3.24M2.65%268.60K
Vanguard Total Stock Mkt Idx Inv3.26M2.62%-72.23K
ARK Genomic Revolution3.24M2.60%274.39K
ARK Genomic Revolution ETF3.22M2.59%-11.50K
Nikko AM ARK Disruptive Innovation A USD3.14M2.55%126.16K
Amova ARK Disruptive Innovation A USD2.97M2.39%-167.66K
Vanguard Small Cap Index2.56M2.06%-13.44K
iShares Russell 2000 ETF2.55M2.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 24, 2025Taich Adam Chief Financial OfficerSell$225.85K
Nov 24, 2025Hindson Benjamin J. See RemarksSell$157.36K
Nov 24, 2025Saxonov Serge Chief Executive OfficerSell$251.94K
Aug 22, 2025Saxonov Serge Chief Executive OfficerSell$128.88K
Aug 22, 2025Taich Adam Chief Financial OfficerSell$307.66K

Insider Transactions Trends

DateBuySell
2025 Q4-3
2025 Q3-3
2025 Q2-3
2025 Q113
2024 Q4-2

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 94.00%, followed by 1.82% insiders and 4.18% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 41.37%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Vanguard group (13.27M shares, 10.73%), Ark investment management (11.89M shares, 9.61%), and Blackrock funding, inc. /de (9.46M shares, 7.64%). Together, they hold 27.98% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of 10x Genomics shares, with 7.41% of its total shares outstanding invested in 9.22M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools